Robeco Institutional Asset Management B.V. Sells 72,302 Shares of Centene Co. (NYSE:CNC)

Robeco Institutional Asset Management B.V. trimmed its holdings in shares of Centene Co. (NYSE:CNC - Free Report) by 7.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 907,692 shares of the company's stock after selling 72,302 shares during the period. Robeco Institutional Asset Management B.V. owned 0.18% of Centene worth $54,988,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of the stock. Park Place Capital Corp lifted its position in shares of Centene by 1,190.0% during the third quarter. Park Place Capital Corp now owns 387 shares of the company's stock worth $29,000 after purchasing an additional 357 shares in the last quarter. Private Trust Co. NA lifted its holdings in Centene by 75.3% in the 3rd quarter. Private Trust Co. NA now owns 773 shares of the company's stock worth $58,000 after buying an additional 332 shares in the last quarter. True Wealth Design LLC purchased a new position in Centene in the 3rd quarter valued at about $66,000. R Squared Ltd purchased a new stake in shares of Centene during the fourth quarter worth about $82,000. Finally, Venturi Wealth Management LLC lifted its stake in shares of Centene by 77.3% in the third quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company's stock worth $88,000 after acquiring an additional 507 shares in the last quarter. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Centene

In related news, CFO Andrew Lynn Asher acquired 17,200 shares of the stock in a transaction on Wednesday, November 13th. The stock was purchased at an average price of $58.14 per share, for a total transaction of $1,000,008.00. Following the transaction, the chief financial officer now owns 486,847 shares of the company's stock, valued at $28,305,284.58. The trade was a 3.66 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Sarah London acquired 4,117 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was purchased at an average price of $60.80 per share, with a total value of $250,313.60. Following the completion of the transaction, the chief executive officer now owns 667,229 shares of the company's stock, valued at approximately $40,567,523.20. This trade represents a 0.62 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired a total of 45,010 shares of company stock worth $2,660,276 in the last 90 days. 0.33% of the stock is owned by company insiders.

Centene Stock Up 1.1 %

NYSE CNC traded up $0.73 during trading on Thursday, reaching $64.64. The company's stock had a trading volume of 2,877,301 shares, compared to its average volume of 4,123,210. The stock has a market capitalization of $32.63 billion, a PE ratio of 11.22, a PEG ratio of 0.85 and a beta of 0.45. Centene Co. has a 1-year low of $55.03 and a 1-year high of $81.42. The business has a 50-day moving average price of $61.01 and a 200-day moving average price of $67.19. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64.

Wall Street Analyst Weigh In

CNC has been the subject of a number of recent analyst reports. Jefferies Financial Group downgraded shares of Centene from a "hold" rating to an "underperform" rating and decreased their price target for the stock from $68.00 to $52.00 in a research report on Tuesday, December 10th. Cantor Fitzgerald reissued an "overweight" rating and issued a $90.00 target price on shares of Centene in a research report on Wednesday, December 11th. Robert W. Baird reduced their price target on shares of Centene from $83.00 to $66.00 and set a "neutral" rating on the stock in a research report on Friday, October 25th. Stephens cut their price objective on Centene from $75.00 to $73.00 and set an "equal weight" rating on the stock in a research note on Friday, December 13th. Finally, Barclays lifted their target price on Centene from $91.00 to $93.00 and gave the stock an "overweight" rating in a research report on Friday, December 13th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $80.92.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.